Annual all-cause mortality rate for patients with diabetic kidney disease in Singapore

Yee Gary Ang, Bee Hoon Heng, Nakul Saxena, Seng Teck Adrian Liew, Phui-Nah Chong, Yee Gary Ang, Bee Hoon Heng, Nakul Saxena, Seng Teck Adrian Liew, Phui-Nah Chong

Abstract

Background: The prognosis of diabetic kidney disease is poor because epidemiological data have shown that all-cause mortality increases with declining renal function. This study aims to estimate the annual mortality rate of diabetic kidney disease stratified by chronic kidney disease (CKD) stages and to identify the predictors of mortality.

Methods: Patients with Stage 3-5 CKD (estimated glomerular filtration rate [eGFR] less than 60 mL/min per 1.73 m2) with diabetic kidney disease from the National Healthcare Group CKD Registry from 1 January 2007 to 31 December 2007 were included in this study. The patients were followed up till 30 November 2013. Cox's proportional hazards regression modelling was used to assess the factors associated with all-cause mortality.

Results: Over a median follow up period of 6.0 years, 985 out of 3008 patients (32.8%) died. Of those who died, 363 (36.9%) died from cardiovascular causes. The annual mortality rate was 64.1 per 1000 individuals (95% confidence interval [CI] 60.2-68.3) and the mortality rate increased with severity of CKD [Stage 3A (37.0), Stage 3B (57.5), Stage 4 (98.3) and Stage 5 (198.5)]. Predictors of mortality were age, male gender, CKD stages, albuminuria, comorbid conditions such as peripheral vascular disease, neuropathy, retinopathy and the use of antiplatelet agents.

Conclusion: Our study estimated the annual all-cause mortality rate for Singaporean patients with diabetic kidney disease by CKD stages and identified predictors of all-cause mortality. This study has affirmed the poor prognosis of these patients and an urgency to intervene early so as to retard the progression to later stages of CKD.

Keywords: Diabetic kidney disease; Epidemiology; Mortality; Prognosis.

Figures

Figure 1
Figure 1
Kaplan–Meier survival estimate.

References

    1. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl. 1):S1–266. Epub 2002/03/21.
    1. Zhang Q.L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117. Epub 2008/04/15. Pubmed Central PMCID: PMC2377260.
    1. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. Epub 2012/12/19.
    1. Perazella M.A., Khan S. Increased mortality in chronic kidney disease: a call to action. Am J Med Sci. 2006;331(3):150–153. Epub 2006/03/16.
    1. Lim C.C., Teo B.W., Ong P.G., Cheung C.Y., Lim S.C., Chow K.Y. Chronic kidney disease, cardiovascular disease and mortality: a prospective cohort study in a multi-ethnic Asian population. Eur J Prev Cardiol. 2014;22(8):1018–1026. Epub 2014/05/27.
    1. Matsushita K., van der Velde M., Astor B.C., Woodward M., Levey A.S., de Jong P.E. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–2081. Epub 2010/05/21. Pubmed Central PMCID: PMC3993088.
    1. Tonelli M., Wiebe N., Culleton B., House A., Rabbat C., Fok M. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034–2047. Epub 2006/06/02.
    1. Woo K.T., Choong H.L., Wong K.S., Tan H.B., Chan C.M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2012;81(10):1044–1045. Epub 2012/05/01.
    1. Loh P.T., Toh M.P., Molina J.A., Vathsala A. Ethnic disparity in prevalence of diabetic kidney disease in an Asian primary healthcare cluster. Nephrology (Carlton) 2015;20(3):216–223. Epub 2014/12/17.
    1. NHG Corporate Yearbook 2014/2015. Singapore: National Healthcare Group; Group Corporate Communications, National Healthcare Group; 88 p.
    1. Heng B.H., Sun Y., Cheah J.T., Jong M. The Singapore National Healthcare Group Diabetes Registry – descriptive epidemiology of type 2 diabetes mellitus. Ann Acad Med Singapore. 2010;39(5):348–352. Epub 2010/06/11.
    1. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154–2169. Epub 2003/10/29.
    1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. NEJM. 2004;351(13):1296–1305.
    1. Group KDIGOKBPW KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013:1–163.
    1. George P.P., Oh C.M., Loh P.T., Heng B.H., Lim F.S. Right-siting chronic kidney disease care-a survey of general practitioners in Singapore. Ann Acad Med Singapore. 2013;42(12):646–656. Epub 2014/01/28.
    1. Sng Q.S. Ministry of Health, Singapore; Singapore: 2011. Primary Care Survey 2010 Profile of Primary Care Patients.
    1. Molnar M.Z., Kalantar-Zadeh K., Lott E.H., Lu J.L., Malakauskas S.M., Ma J.Z. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol. 2014;63(7):650–658. Epub 2013/11/26. Pubmed Central PMCID: PMC3944089.
    1. van der Velde M., Matsushita K., Coresh J., Astor B.C., Woodward M., Levey A. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79(12):1341–1352. Epub 2011/02/11.
    1. Saito Y., Morimoto T., Ogawa H., Nakayama M., Uemura S., Doi N. Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial. Diabetes Care. 2011;34(2):280–285. Epub 2011/01/29. Pubmed Central PMCID: PMC3024334.

Source: PubMed

Подписаться